SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 99,500 shares of its common stock to eleven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Best Real Money Online Casino in USA goes to 7Bit Casino Rated by UJN - April 19, 2025
- St. Charles Residents Urged to Fortify Fencing Against Severe Weather with Fence and Deck Depot’s Expert Guidance - April 18, 2025
- Machine Learning Engineer Interview Course 2025 – Interview Kickstart Releases ML Engineer Course With Interview Prep - April 18, 2025
